Ars Investment Partners, LLC Red Hill Biopharma Ltd. Call Options Transaction History

Ars Investment Partners, LLC

  • $976 Million
  • Q3 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding RDHL

# of Institutions
2
Shares Held
40.4K
Call Options Held
0
Put Options Held
0
View Full List

About RedHill Biopharma Ltd.

RDHL Quotes by TradingView
  • Ticker RDHL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 63,823,500
  • Market Cap $465M
  • Description
  • RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...
More about RDHL
Track This Portfolio

Track Ars Investment Partners, LLC Portfolio

Follow Ars Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ars Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ars Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email